Skip to content
← Full study record

NCT01258998 · OUTCOME

Number of Participants With Change in Biomarker Levels With p Values <0.05

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · Source last updated 2020-11-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Baseline to up to 30 days post-treatment

What was measured

The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.

Groups in this outcome

Akt Inhibitor MK2206

Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Akt Inhibitor MK220636

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Akt Inhibitor MK22060Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      36
    units
    Participants
description
The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.
groups
  1. description
    Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
    id
    OG000
    title
    Akt Inhibitor MK2206
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Baseline to up to 30 days post-treatment
title
Number of Participants With Change in Biomarker Levels With p Values <0.05
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice